Diagnostic Medical Systems S.A. (EPA:ALDMS)
France · Delayed Price · Currency is EUR 1.090
+0.010 (0.93%)
Aug 3, 2026, 2:54 PM CET
EPA:ALDMS Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 28 | 33 | 15 | 20 | 1,505 | 20 | |
Market Cap Growth | -1.67% | 118.95% | -24.21% | -98.68% | 7549.86% | -30.68% |
Enterprise Value | 41.1 | 46 | 31.08 | 36.46 | 1,518 | 33.04 |
Last Close Price | 1.09 | 1.27 | 0.75 | 1.14 | 1.01 | 1.22 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.53 | 0.66 | 0.33 | 0.47 | 42.66 | 0.54 |
PB Ratio | 1.35 | 1.72 | 1.17 | 1.60 | 96.07 | 1.05 |
P/TBV Ratio | - | - | - | - | 2.57 | 3.40 |
P/FCF Ratio | - | - | 500.74 | - | - | - |
P/OCF Ratio | 56.43 | 66.31 | 4.17 | - | 1567.19 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.78 | 0.92 | 0.67 | 0.87 | 43.04 | 0.91 |
EV/EBITDA Ratio | 11.19 | 12.53 | - | 17.74 | - | 24.01 |
EV/EBIT Ratio | 34.80 | 38.95 | - | - | - | - |
EV/FCF Ratio | - | - | 1036.04 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.73 | 0.73 | 1.09 | 1.24 | 0.65 | 0.49 |
Debt / EBITDA Ratio | 5.10 | 5.10 | - | 9.76 | - | 11.53 |
Debt / FCF Ratio | - | - | 669.13 | - | - | - |
Net Debt / Equity Ratio | 0.61 | 0.61 | 1.15 | 1.24 | 0.70 | 0.62 |
Net Debt / EBITDA Ratio | 3.16 | 3.16 | -35.68 | 7.44 | -4.56 | 8.48 |
Net Debt / FCF Ratio | -4.79 | -4.79 | 491.13 | -3.50 | -2.59 | -1.68 |
Asset Turnover | 0.86 | 0.86 | 0.88 | 0.80 | 0.66 | 0.73 |
Inventory Turnover | 2.11 | 2.11 | 1.99 | 1.93 | 1.85 | 1.96 |
Quick Ratio | 0.66 | 0.66 | 0.55 | 0.51 | 0.50 | 0.52 |
Current Ratio | 1.37 | 1.37 | 1.29 | 1.44 | 1.41 | 1.34 |
Return on Equity (ROE) | 0.70% | 0.70% | -18.73% | -61.67% | -34.39% | -13.84% |
Return on Assets (ROA) | 3.26% | 3.26% | -0.61% | -4.31% | -10.96% | -4.70% |
Return on Invested Capital (ROIC) | 5.88% | 6.21% | -1.10% | -7.79% | -19.13% | -7.46% |
Return on Capital Employed (ROCE) | 3.61% | 3.61% | -1.16% | -7.25% | -17.96% | -7.77% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
FCF Yield | - | - | 0.20% | - | - | - |
Buyback Yield / Dilution | -20.91% | -8.57% | -12.41% | 0.00% | -25.66% | 0.00% |
Total Shareholder Return | -20.91% | -8.57% | -12.41% | 0.00% | -25.66% | 0.00% |